[VRTX] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
10-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -42.26%
YoY- 152.01%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 333,994 336,006 418,305 438,737 563,340 659,200 114,424 103.58%
PBT -80,772 -5,112 -14,405 87,908 210,801 200,610 -174,870 -40.10%
Tax -2,696 21,355 20,063 32 22,660 -27,842 24,448 -
NP -76,148 -57,543 -64,931 91,590 158,629 221,110 -174,069 -42.22%
Tax Rate - - - -0.04% -10.75% 13.88% - -
Total Cost 410,142 393,549 483,236 347,147 404,711 438,090 288,493 26.29%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -22.80 -17.13 -15.52 20.88 28.16 33.54 -152.13 -71.62%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -0.35 -0.27 -0.31 0.44 0.76 1.06 -0.85 -44.50%
EPS Diluted -0.35 -0.27 -0.31 0.43 0.72 1.02 -0.85 -44.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.